<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">USA Study<sup>a</sup>
<br/>  <br/>(N=499 patients) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Mycophenolate mofetil<br/>2 g/day<br/>(n=167 patients)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Mycophenolate mofetil<br/>3 g/day<br/>(n=166 patients)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Azathioprine<br/>1 to 2 mg/kg/day (n=166 patients)<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">All treatment failures <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">31.1%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">31.3%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">47.6%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Early termination without prior acute rejection<sup>b</sup>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">9.6%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">12.7%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">6.0%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Biopsy-proven rejection episode on treatment <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">19.8%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">17.5%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">38.0%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Europe/Canada/ Australia Study<sup>c </sup>
</content>
<br/>
<content stylecode="bold">(N=503 patients) </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Mycophenolate mofetil</content>
<br/>
<content stylecode="bold">2 g/day</content>
<br/>
<content stylecode="bold">(n=173 patients)</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Mycophenolate mofetil</content>
<br/>
<content stylecode="bold">3 g/day</content>
<br/>
<content stylecode="bold">(n=164 patients)</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Azathioprine</content>
<br/>
<content stylecode="bold">100 to 150 mg/day (n=166 patients)</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">All treatment failures <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">38.2%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">34.8%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">50.0%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Early termination without prior acute rejection<sup>b</sup>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">13.9%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">15.2%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">10.2%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Biopsy-proven rejection episode on treatment <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">19.7%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">15.9%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">35.5%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Europe Study<sup>d</sup>
</content>
<br/>
<content stylecode="bold">  </content>
<br/>
<content stylecode="bold">(N=491 patients) </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Mycophenolate mofetil</content>
<br/>
<content stylecode="bold">2 g/day</content>
<br/>
<content stylecode="bold">(n=165 patients)</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Mycophenolate mofetil</content>
<br/>
<content stylecode="bold">3 g/day</content>
<br/>
<content stylecode="bold">(n=160 patients)</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Placebo</content>
<br/>
<content stylecode="bold">  </content>
<br/>
<content stylecode="bold">(n=166 patients)</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">All treatment failures <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">30.3%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">38.8%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">56.0%<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Early termination without prior acute rejection<sup>b </sup>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">11.5%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">22.5%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">7.2%<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">Biopsy-proven rejection episode on treatment <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">17.0%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">13.8%<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">46.4%<br/>
</td>
</tr>
</tbody>
</table>